DrugsControl Media Services

News Detail

SEC approves import and marketing of Eli Lilly’s anti-cancer drug selpercatinib (25-05-2022)

New Delhi, 25 May 2022: The Subject Expert Committee (SEC) of the country’s drug regulator has recommended granting permission to multinational drug major Eli Lilly to import and market anti cancer drug selpercatinib capsules in 40 mg and 80 mg dosages, subject to condition......
View Details

Source : Pharmabiz

Related News